PILL250117P13000
- 0.00
- 0.000.00%
Direxion Daily Pharmaceutical & Medical Bull 3X Shares Newsroom
10 Levered Big-caps That May Face Higher Refinancing Expenses
Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More
Organon Snaps Six Days of Winning Streak
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Lilly Signs Licensing Deal With Mediar for IPF Drug
"Eli Lilly In Advanced Talks To Buy U.S. Cancer Biotech For Up To $2.5B; Scorpion's Drug Candidate Inhibits A Mutation That Is A Major Driver Of Breast, Gynaecological And Head And Neck Cancers" - Financial Times
TD Synnex, Walgreens, Savers Value Village And Other Big Stocks Moving Higher On Friday
Royalty Pharma Shares Are Trading Higher After the Company Announced It Increased Its Quarterly Dividend.
Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure
Pfizer Says Its Sasanlimab In Combination With Bacillus Calmette-Guérin (BCG) Improves Event-Free Survival In Patients With BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
On Thursday, Alchemab Therapeutics Entered A Collaboration With Eli Lilly To Discover, Develop, And Commercialize Up To Five Therapeutics For Amyotrophic Lateral Sclerosis; Alchemab Will Receive An Undisclosed Upfront Payment And Is Eligible To...
Morgan Stanley's outlook for the top ten investment trends in 2025: the revival of nuclear energy, the AI revolution in the financial Industry, quantum computing, oral weight loss medications...
Morgan Stanley pointed out that historically, popular themes with strong profit momentum tend to have a strong sustainability, such as AI, defense spending, and obesity drugs; negative prices and quantum computing are expected to emerge as new investment hotspots.
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Zymeworks Says It Has Enough Cash to Operate Through H2 2027